Panion & Bf Biotech Inc.

NT$48.95As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1760Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (2.54%)
Div yield 4.09%
ROE 11.63%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.07)
PE TTM 19.58
TSR TTM (23.57%)
Mkt cap NT$4.197B
ROIC 10.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$60
21.64%
(25.32%)
Hold 12|9|2|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.65
0.70
0.70
0.71
23.40%
26.85%
24.93%
15.68%
RevenueNT$M
213.0
214.1
209.8
210.4
13.74%
9.28%
1.88%
(1.38%)
Peers (US$126.8M)
Cap (US$)
PE
127.2M
24.59x
Capital
TTM
5Y
10Y
Leveragex
3.728
—
—
EBIT/Intx
0.920
0.096
0.096
Own earn%
(29.55)
(9.57)
(19.16)
Sh yield%
32.36
31.01
32.78
Owners
Insiders/Inst%
2.85
71.54
Short interest%
4.66
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
29–36
$1 testx
0.0
Incr. ROIC%
127